If you didn't find what you were looking for, try a new search!
European-based Unilabs has deployed the SOPHiA DDM™ Platform across its network in Switzerland to support cancer diagnostics and treatment Boston, MA and Rolle, Switzerland, April 17, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in [...]
BOSTON and LAUSANNE, Switzerland, July 22, 2021 — SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today the pricing of its initial public offering of 13,000,000 ordinary shares at a [...]
Interview with Jurgi Camblong, CEO of SOPHiA GENETICS SOPHiA GENETICS was founded in 2011 by Jurgi Camblong, Lars Steinmetz and Pierre Hunter. Nine years on, the company has more than 350 employees across the world with offices in Switzerland, France [...]
SOPHiA GENETICS Raises $110 Million in Oversubscribed New Funding Round Supporting the Company's Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine - SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round [...]
SOPHiA GENETICS Expands its Executive Team, Naming Lara Hashimoto Chief Business Officer Lausanne, Switzerland, and Boston, United States, April 8, 2020 - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Lara Hashimoto has joined its Executive Team as Chief [...]
for its Solid Tumor Solution for accurate cancer detection. Lausanne, SWITZERLAND – 11 April 2019: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the CE-IVD marking of its Solid Tumor Solution (STS), a new step in the fight against cancer. [...]
SOPHiA GENETICS raises $77 million to accelerate the democratization of data-driven medicine San Francisco, Jan. 4, 2019: SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data- [...]
Milan – Italy, June 16, 2018: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today at the European Human Genetics Conference (ESHG 2018) that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS), the creators of Alamut®, the [...]
The Myeloid Solution by SOPHiA GENETICS is the best-in-class molecular diagnostic application which empowers clinicians to more precisely diagnose hematological disorders Lausanne, SWITZERLAND – 06th February 2018: SOPHiA GENETICS, global leader in Data-Driven Medicine, unveiled today the world’s first capture-based myeloid [...]